余司文,武强,王艳华,贺乐奇,沈芳
YU Siwen,WU Qiang,WANG Yanhua,HE Leqi,SHEN Fang

• 1:复旦大学附属上海市第五人民医院检验科

摘要(Abstract)：

目的:探讨2型糖尿病(T2DM)患者血小板参数、血小板聚集功能(PAgT)、血小板表面相关膜糖蛋白(CD41b、CD61和CD62P)及线粒体膜电位(Δψm)表达的临床意义。方法:选取75例T2DM患者和50例健康对照者,取清晨空腹静脉血,检测血小板计数(PLT)、血小板平均体积(MPV)、血小板压积(PCT)、血小板分布宽度(PDW)、PAgT、CD41b、 CD61、CD62P及Δψm的变化。结果:与对照组比较,T2DM患者MPV、PDW及PAgT水平均升高(P<0.05);Δψm表达降低(P<0.05); CD41b、CD62P表达升高(P<0.05)。结论:T2DM患者部分血小板相关参数发生变化,这些参数的变化可能是糖尿病患者微血管病变的早期指标。
Objective: To probe into the clinical significance of platelet parameters, platelet aggregation function(PAgT), platelet surface associated membrane glycoprotein(CD41b、CD61 and CD62P) and mitochondrial, membrane potential(ΔΨm) expression in patients with type 2 diabetes mellitus(T2DM). Methods: 75 cases with T2DM and 50 healthy people were involved, mensuration of platelet parameters(PLT, MPV, PCT,PDW, PAgT, CD41b, CD61, CD62P, ΔΨm) expressions were respectively given to 75 patients with T2DM and 50 healthy controls to observe the difference between the two groups. Results: Compared with the control group, the diabetic group showed an increase in PDW,MPV and PAgT(P<0.05); ΔΨm expression decreased(P<0.05); the CD41b and CD62P expression rose up(P<0.05). Conclusion: MPV, PDW, PAgT, CD41b and CD62P expression level increased significantly and ΔΨm expression is reduced in patients with T2DM. These parameter changes can be used as early indicators to assess the risk of vascular complications for T2DM.

关键词(KeyWords)： 糖尿病;血小板;血小板膜糖蛋白类;血小板聚集率;血小板线粒体膜电位;微血管病变
diabetes;platelet;platelet membrane glycoprotein;platelet aggregation rate;platelet mitochondrial membrane potential;microvascular lesion

Abstract:

Keywords:

基金项目(Foundation): 闵行区卫生和计划生育委员会项目(2016MW06)

作者(Author): 余司文,武强,王艳华,贺乐奇,沈芳
YU Siwen,WU Qiang,WANG Yanhua,HE Leqi,SHEN Fang

DOI: 10.19367/j.cnki.1000-2707.2019.09.024

参考文献(References)：

• [1] VANHOUTTE P M,ZHAO Y,XU A,et al.Thirty yeara of saying No:sources,fate,actions.and misfoutunes of the Endothelium-Derived vadofilatot mediatou[J].Circ Res,2016,119(2):375-396.
• [2] CHENG D,ZHAO J,JIAN L,et al.Relationship between red celldistebutian width and warly renal injury in paients with gestational diabetes mellitus[J].Ren Fail,2016,7(12):1-6.
• [3] 季发权,吉蘅山,张龙江,等.2型糖尿病患者骨密度变化及其相关影响因素[J].贵州医科大学学报,2018,43(9):1109-1113.
• [4] WANG W Q,LU J L.Molecular mechanisms of type 2 diabetes mellitus in Chinese (in Chinese)[J].Sci Sin Vitae,2018,48:840-846.
• [5] SHEN W Q,XING Y F,HUANG L.Changes and clinical significance of platelet parameters and hemorrhenology in diabetic kidney disease[J].Clinical Medicine of China,2016,32(7):622-62.
• [6] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018,38(4):292-344.
• [7] 李若淳,刘建红,王小星,等.血清胱抑素C联合视黄醇结合蛋白在早期糖尿病肾病诊断中的价值[J].贵州医科大学学报,2017,42(12):1-4.
• [8] ZACCARDI F,ROCCA B,PITOCCO D,et al.Platelet mean volume,distebution width and count in type 2diabetes,impaired fasting glucose and mtiabolic syndrome:a meta-analysis [J].Diabetes Metab Res Rev,2015,31(4):402-410.
• [9] 梁旭满.2型糖尿病患者血小板参数监测及微血管病变的临床研究[J].贵州医科大学学报,2016,22(4):379-381.
• [10]HUANG T T,MIAO L F,YI J.Clopidogrel resistance in coronary artery disease and hypertension patients with high blood sugar:involving increased platelet ATP content and mitochondrial membrane potential decreased[J].Chin J Arterioscler,2017,25(10):1025-1029.
• [11]赵志勇.血小板四项参数与2型糖尿病并发缺血性脑卒中的关系[D].南京:南京医科大学,2017.
• [12]KROENER G,REED J C.Mitochondrial control of cell death[J].Nat Med,2000,6(5):513-519.
• [13]ZHANG Z H.Expression and significance of platelet parameters,fibrinogen and D-dimer in type 2 diabetic patients with microangiopathy[J].China Medical Herald,2014,11(16):70-73.
• [14]ENQUBAHRIE D A,FELDMAN H A,HOELSCHE D H,et al.Serum homocydteine and folate concentrations among a US cohort of adlledcents before and after folicacid fortification[J].Public Health Nutr,2012,15(10):1818-1826.
• [15]LIANG H X,ZHANG Z A,PANG Z X.Key protein disulfide isomerase-platelet membrane glycoproteins Ⅱ b Ⅲ a receptor Expression analysis in type 2 diabeticmic[J].Shanxi Med J,2018,47(23):2800-2802.
• [16]WANG L,XU Z Y,WU B.The Changes of Glycoprotein on the surface of platelets in patients with type 2 diabetes[J].Chinese Journal of Thrombosis and Hemostasis,2015,21(6):358-363.
• [17]Li Y T,ZHANG L L,ZHANG Q L.Combined detection for markers of activated platelet CD62P,CD63 in early kidneymicroangiopathy of diabetic mellitus[J].Journal of Hebei Medical University,2015,36(5):551-553.
• [18]STELLOS K,BIGALKE B,STAKOS D.et al.Platelet-bound Pselectin expression in patients with coronary artery disease:impact on clinical presentation and myocardial necrosis,and effect of diabetes mellitus and anti-platelet medication[J].J Thromb Haemost,2010,8:205-207.
• [19]张鸿雁.2型糖尿病周围神经病变患者血小板膜蛋白的表达[D].石家庄:河北医科大学,2015.
• [20]ZHU Y K,CAO L,ZHAO B Z,et al.Expression of GPⅡb/Ⅲa and GMP-140 platelet aggregation in patients with type2 diabetes mellitus[J].Chin J Gen Med,2002,18:626-628.
• [21]GOCMEN A Y,OCAK G A,OZBILIM G,et al.Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats[J].Can J Physiol Pharmacol,2013 ,91:680-685.

文章评论(Comment)：